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MEDICAL APPROACH TO THE DIAGNOSIS OF KIDNEY STONES* 
BOY FR.\ME, M.D.** 
A gratifying experience in the professional life of a physician is that of detecting 
an underiying metabolic disorder in a patient with kidney stones. It is especially 
satisfying if the defect can be corrected and the recurrence of kidney stones thereby 
prevented. 
When a patient with a kidney stone is first seen, it is often difficult to decide 
on the extent of the initial medical evaluation. Many patients pass but one stone 
in a lifetime and in this instance detailed investigation hardly seems warranted. 
However, when the patient is first seen it is not known whether or not that particular 
patient will be the one to have recurrent stone formation. Perhaps at the time of 
the next patient contact urinary tract infection, renal insufficiency, or both, will be 
present which will complicate metabolic study and treatment. 
What are the diagnostic steps from the metabolic point of view in a patient 
with recurrent nephrolithiasis? Certainly the kidney stone should be obtained if at 
all possible for crystal analysis. Unfortunately padents will often have an extensive 
metabolic investigation and the physician later learns that the patient has his kidney 
stone at home in a dresser drawer as a souvenir. 
Numerous techniques are available for stone analysis. Only the quality of crystal 
present in the stone is important, not the quantity. It must be remembered that 
kidney stones may be laminated and that the stone nucleus alone may harbor the 
clue to the basic metabolic error. With experience many stones can be identified by 
the naked eye with the aid of a hand lens. The spiked calcium oxalate stone which 
may be particularly painful is quite characteristic. Distinct and multiple laminations 
may give a clue to the presence of calcium phosphate stones. The cysUne stone 
is smooth in outline, waxey in appearance and homogeneous in texture. Chemical 
spot tests of either the urine or urinary sediment are available for crystal identification. 
Microscopic examination of the urinary sediment may be of help but may also be 
misleading. The hexagonal crystals of cystine are most distinctive and unforgetable 
once observed under the microscope. It must be remembered that the crystal identified 
*Address given at the Fourth Annual Michigan Kidney Disease Symposium, June 4-5th, Flint, 
Michigan. 
**Fifth Medical Division. 
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in the urinary sediment may not be the same crystal present in the kidney stone, 
itself. This is especially true after various forms of treatment have been initiated 
that predispose to crystal formation different from that originally present. 
In some institutions polarized microscopy and x-ray diffraction are used for 
crystal identification but require special equipment and considerable experience. At 
the Henry Ford Hospital we are fortunate in having Mr. Parsons of the Physics 
Department who has analyzed approximately 1200 kidney stones for crystal structure 
by x-ray diffraction. With his techniques and experience he is able to give a prompt 
report of the crystal structure in kidney stones as well as in other body concretions. 
Many times he has given a correct lead to the underlying metabolic defect, particularly 
with regards to cystine stones. For practical purposes stone analysis should inform the 
physician whether he is basically dealing with a defect in calcium, cystine or uric 
acid metabolism. The situation may be complicated in those patients who- pass stones 
containing several different types of crystals. For instance, a patient initially may 
have passed a uric acid or cystine stone, but after treatment with urinary alkalinization 
superimposed calcium stones may form. 
CALCIUM-CONTAINING STONES 
In temperate United States calcium-containing kidney stones present the greatest 
difficulty in diagnosis and treatment. The important first step in evaluating the patient 
with a calcium stone is to determine whether or not hypercalcemia is present. The 
serum calcium determination and its clinical interpretation is fraught with many errors 
and difficulties. Hospital laboratories in general do less than an ideal job in the accurate 
determination of the total serum calcium. Solutions of known calcium composition 
have been sent as unknowns to laboratories in community hospitals and the values 
obtained have ranged up to 100% in error.' The normal range and standard deviation 
should be defined for each hospital laboratory. This is not easy because it is not 
always certain that supposed normal controls do, indeed, have normal serum calcium 
levels. Nevertheless, each laboratory should periodically insert a series of so-called 
normal serum samples for calcium determination in an attempt to keep a check on 
standards and normal values. There is no data as to whether a diurnal variation in 
the level of serum calcium exists; if it occurs, it must be of a minor degree. In normal 
subjects, a reduction in oral calcium intake for several days will result in a slight 
but significant depression of the mean serum calcium.^ Also, after the ingestion of 
several glasses of milk, the serum calcium may be slightly increased. It is, therefore, 
important to obtain the serum calcium when patients have been on an average 
calcium intake and also when in the fasting state. A difference of .2 to .3 mgm% 
can be important when one is evaluating patients with borderline hyper- or hypocalcemia. 
With most methods, a value over 10.5 mgm% should be suspect for hypercalcemia. 
There is evidence to suggest that climate may affect levels of serum calcium. 
In a recent study' serum calcium and also serum phosphorus and antirachitic 
levels were found to average higher in Puerto Rican than in Michigan women, 
perhaps a reflection of greater exposure to sunshine in the former. It is also possible 
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that serum calcium levels are normally higher during the summer months than in the 
winter. This has previously been shown to be true in patients with sarcoid who are 
thought to be unduly sensitive to the hypercalcemic action of vitamin D. 
Prolonged venous stasis and vigorous forearm exercise during venipuncture have 
also been shown to increase the level of serum calcium to a significant degree.'' This 
occurs since protein free plasma is lost from the occluded vein resulting in a relative 
increase in plasma proteins to which calcium is bound. It is, therefore, important 
that technicians be instructed to keep the arm tourniquet on as briefly as possible 
and to have the patient refrain from using vigorous forearm contraction during 
the venipuncture. I t has also recently been determined that the serum calcium value 
may be increased when the serum is allowed to come in contact with cork stoppers.^  
Therefore, rubber stoppers are recommended, especially when samples are mailed 
and the serum inadvertently is in contact with the stopper for long periods of time. 
Physicians seldom reflect on the complexity of the calcium fractions when 
ordering a serum calcium. The non-filterable calcium accounting for approximately 
45% of the total serum calcium is bound primarily to albumin and, to a lesser 
extent, to various globulins. The ultrafilterable fraction, including complexed calcium, 
accounts for approximately 55%.' A reduction in serum albumin for any reason 
is one of the most common causes of a depressed total serum calcium. Under these 
circumstances, tetany is seldom present since the concentration of ionic calcium is usually 
maintained. An elevation of the total serum calcium does not normally occur as a 
result of increased protein binding that might occur in various hypergammaglobulinemic 
states such as sarcoidosis and multiple myeloma. The hypercalcemia here is due to 
other mechanisms. Complexing of serum calcium to bicarbonate, citrate, phosphate 
and other ions accounts for a relatively small portion of the total serum calcium and 
ordinarily is not of clinical importance. However, in renal insufficiency, the complexed 
fraction may be increased, primarily because of binding with sulphates and phosphates. 
There have been numerous attempts to improve the significanse of the serum 
calcium value by fractionation into its various components. Determination of the 
ionic fraction is too difficult for most general hospital laboratories and has not as 
yet been proved more helpful than the determination of the total serum calcium 
alone in the evaluation of hypercalcemic states. A recent study of 166 serum 
ultrafilterable calcium determinations in 150 individuals showed nO' constant deviations 
of diagnostic significance in patients with malignancies, hyperparathyroidism, hypo-
parathyroidism, multiple myeloma, sarcoidosis, connective tissue disorders, muscle 
dystrophy, vitamin D resistant rickets and osteoporosis.' The total serum calcium, 
therefore, if done accurately, is sufficient in evaluation of hypercalcemic states. 
Once definite hypercalcemia has been established in a patient with nephrolithiasis, 
many underlying diseases need be considered. Table I lists the more common conditions 




Causes of Hypercalcemia and Nephrolithiasis 
1. Hyperparathyroidism 
2. Sarcoidosis 
3. Malignancy, myeloma 
4. Hypervitaminosis D 
6. Immobilization 
a) Osteoporosis 
b) Paget's disease 
7. Milk alkali syndrome 
The diagnosis of hyperparathyroidism is largely a diagnosis of exclusion since 
there is no specific laboratory proof. If other causes of hypercalcemia can be excluded 
in a patient with nephrolithiasis, hyperparathyroidism is the most likely diagnosis. 
The presence of hypercalcemia in a patient with sarcoidosis or thyrotoxicosis does 
not automatically exclude hyperparathyroidism. There are numerous case reports in 
the literature where hyperparathyroidism has been present in conjunction with other 
hypercalcemic conditions. While hypercalcemia is common in malignancy, myeloma 
and thyrotoxicosis, nephrolithiasis appears rarely in these conditions. Perhaps this 
is a reflection of the short life expectancy in most patients with malignancy and the 
early diagnosis usually made in thyrotoxicosis. 
The serum inorganic phosphrous is of relatively little value in the differential 
diagnosis of hypercalcemia and nephrolithiasis. As with the determination of serum 
calcium, its accuracy and proper evaluation is fraught with pitfalls. Dietary restriction 
of phosphorus will result in a depression of the fasting serum inorganic phosphorus. 
The administration of nonabsorbable alkalis will also lower the serum phosphorus 
and is one of the most common causes of hypophosphatemia in patients with dyspepsia 
and peptic ulcer. While classically the serum inorganic phosphorus is depressed in 
hyperparathyroidism, a normal or even increased value is fully compatible with the 
condition, especially in the presence of renal insufficiency. Hypophosphatemia may 
occur in almost all other hypercalcemic states and is not particularly helpful in dif-
ferentiating hyperparathyroidism from other causes of hypercalcemia. It is to be re-
membered that the serum inorganic phosphorus is ordinarily higher in infants and 
also in postmenopausal women. 
Many other laboratory tests and procedures have been utilized in the evaluation 
of patients with calcium-containing stones. The serum protein electrophoresis is 
helpful in excluding myeloma and sarcoidosis. The serum alkaline phosphatase may 
be elevated in most conditions giving rise to hypercalcemia and, therefore, is of little 
help except in association with subpereosteal resorption when it supports the diagnosis 
of hyperparathyroidism. In the differential diagnosis of hypercalcemic states, the 
cortisone tolerance test may be helpful. When cortisone is administered in the dose 
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of 150 mgm. a day for ten days, the serum calcium will frequentiy return to normal 
in sarcoid, hypervitaminosis D and in many malignant states. The hypercalcemia of 
hyperparathyroidism, on the other hand, is generally unaffected by such a course 
of corticosteroids, but exceptions have been noted. 
During the past few years many attempts have been made to utilize the phospha-
turic effects of parathyroid hormone in the diagnosis of hyperparathyroidism. The 
percent tubular reabsorption of phosphorus (%TRP), phosphate clearance (Cp) and 
the phosphate excretion index (PEI) popularized by various authors have been attempts 
at improving this diagnostic approach. Interested physicians in most clinics have 
lost enthusiasm for these tests since they are not specific and both false positive 
and false negative results have been reported. They have never been especially 
helpful to us in the diagnosis of any patient with hyperparathyroidism, and we now 
use them only in borderline cases and only in conjunction with the total clinical and 
laboratory information. 
Various calcium infusion tests have also been developed in an attempt to improve 
diagnosis in hyperparathyroid states. These tests are based on the theory that intra-
venous calcium inhibits synthesis and release of parathyroid hormone, thereby 
reducing urinary phosphorus excretion. Supposedly in the patient with an autonomous 
parathyroid adenoma, calcium infusion is unable to effect parathyroid hormone 
release. Under these circumstances, urinary phosphorus either remains the same 
or may be increased. Goldsmith has developed a four hour test utilizing calcium 
infusion while measuring the effect on the phosphate-creatinine excretion ratio 
in the urine. In his experience this ratio is normally reduced during the second 
hour after calcium infusion but is increased in patients with hyperparathyroidism. 
With the use of his infusion test. Goldsmith has diagnosed hyperparathyroidism in 
patients with nephrolithiasis, even in the absence of hypercalcemia. We have observed 
both false positive and false negative results with calcium infusion tests which reduces 
their value in diagnosis. There is recent evidence to suggest that calcium infusion 
may influence the renal excretion of phosphorus, even in the absence of the parathyroid 
glands which, if true, would weaken the physiologic basis for the test. It is also 
to be remembered that the parathyroid glands should theoretically be suppressed in 
other hypercalcemic states. Under these circumstances calcium infusion may not 
affect the already suppressed parathyroid glands and resuUs similar to those expected 
in hyperparathyroidism may be observed. In other words, the calcium infusion test 
does not idfferentiate hyperparathyroidism from other hypercalcemic states. 
There have been exciting new advances in methods to assay blood levels of 
parathyroid hormone. Radioimmunoassay techniques at the present time are being 
improved and soon may be sensitive enough to be of greater help in the diagnosis 
of hyperparathyroidism. Insulin and growth hormone appear to be better antigenic 
stimuli than parathyroid hormone and presently assays for these hormones are ap-
proximately 5 times as sensitive as that for parathormone. New advances in this 
area of diagnosis are expected soon. 
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HYPERCALCIURIA AND NEPHROLITHIASIS 
When hypercalcemia has been ruled out in a patient with a calcium-containing 
kidney stone, an attempt should be made to evaluate the presence of hypercalciuria. 
Renal excretion of calcium is complex and some of the important factors are only 
beginning to be understood. 
The level of ultrafilterable serum calcium and the glomerular filtration rate 
determine the concentration of calcium in the glomerular filtrate. As renal damage 
progresses in hypercalcemic states, the amount of filtered calcium and hence the 
amount of calcium appearing in the urine is frequently reduced. There is evidence 
that complexed calcium is less readily reabsorbed in the renal tubules than is ionic 
calcium since infusion of such complexing substances as citrate, sulfate and EDTA 
greatly increases the urinary excretion of calcium. Current data suggests that para-
thyroid hormone increases tubular reabsorption of calcium. Hence, after the ad-
ministration of parathyroid hormone the urinary excretion of calcium is initially 
decreased and only later when hypercalcemia accounts for an increased filtered load 
does the urinary calcium excretion increase. Following parathyroidectomy on the 
other hand, urinary calcium is initially increased and only after the serum calcium 
falls does the urinary excretion of calcium decrease. It has been stated that in 
mildly hypercalcemic states a normal or reduced urinary calcium concentration sup-
ports the diagnosis of hyperparathyroidism over other causes of hypercalcemia. The 
reliability of this thesis has not been fully tested. Vitamin D influences renal excretion 
of calcium, especially when administered in large doses. In some instances, such 
as in hypoparathyroidism, administration of vitamin D is followed by hypercalciuria 
before elevation of the serum calcium occurs. Hence, the effectiveness of therapy 
with vitamin D in hypoparathyroidism cannot be evaluated by the response in urinary 
calcium alone. Solute diuresis, especially after intravenous sodium salts, enhances 
urinary excretion of calcium and in many respects renal tubular handling of calcium 
and sodium are parallel. Current evidence based on micropuncture techniques' in-
dicates that most of the filtered calcium is reabsorbed in the proximal convoluted 
tubules, but some reabsorption occurs in the distal tubules as well. 
The determination of the 24 hour urine calcium is of value only if considered in 
light of the total clinical and laboratory picture. There has been considerable dis-
agreement as to the normal 24 hour urine calcium excretion value. This is due to 
the fact that different authors have used varying degrees of dietary calcium restriction 
during the test. In general, most normal subjects excrete less than 300 mgm. of 
calcium per 24 hours on a diet of average calcium intake. When milk and other 
dietary products are removed from the diet, urinary calcium excretion will generally 
be less than 200 mgm. per 24 hours. I f a markedly restricted calcium intake of less 
than 150 mgm. in 24 hours is taken, the urinary calcium excretion should then be 
less than 150 mgm. per 24 hours. The patient as well as the nurse should be instructed 
in the correct urine collection technique and also adequate urinary collection should 
be confirmed by urinary creatinine determination. It is important to remember 
that calcium salts may precipitate on the walls of the specimen bottle and thereby 
falsely reduce the urinary calcium value. A small amount of concentrated acid added 
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to the urine collection bottle will keep the urinary calcium in solution. However 
this makes it more difficult for the laboratory in that the specimen then has to be 
neutralized before the calcium determination is performed. 
Determination of the urinary pH may be of help in the evaluation of renal 
lithiasis, especially if the urine is free of infection. A persistently alkaline urine 
should always raise the question of an underlying renal tubular defect such as renal 
tubular acidosis. In this case hyperchloremic acidosis may be apparent from the 
results of the serum electrolytes. In borderline cases, the ammonium chloride load 
test may be used to determine whether there is a defect in the renal mechanisms for 
handling an acid load. Ammonium chloride solution, . 1 gram per kilo, administered 
in a palatable solution with observation of the urinary pH for 6-7 hours will help 
define such cases. A decrease in the urinary pH below 5.5 indicates adequate renal 
tubular mechanisms for urine acidification and virtually rules out renal tubular acidosis. 
Measuring the hydrogen ion clearance index as proposed by Elkinton is a more refined 
way of testing for renal tubular acidosis." 
Determination of the 24 hour urine oxalate will be of help in the diagnosis of 
the rare inborn error of metabolism oxalosis, which gives rise not only to repeated 
calcium oxalate stones, but also tO' a general tissue deposition of calcium oxalate.' 
In this instance, there is a persistent and excessive excretion of urinary oxalate 
greater than 100 mgm. per 24 hours. It is to be remembered that calcium oxalate 
nephrolithiasis is very common and most patients with such stones do not have a 
metabolic error in oxalic acid metabolism. In these latter patients, the daily urinary 
oxalate excretion is less than 50 mgm. 
Table I I is a list of the more common causes of hypercalciuria that are to be 
considered in the differential diagnosis of the patient with kidney stones and increased 
calcium in the urine. 
Table I I 




4. Osteoporosis (certain types) 
5. Cushing's syndrome 
6. Metastatic cancer, myeloma 
7. Renal tubular acidosis 
8. Fanconi syndrome 
9. Vitamin D intoxication 
10. Sarcoidosis 
11. "Idiopathic" hypercalciuria 
12. Paget's disease 
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It is important to remember that the urinary calcium concentration is only one 
of many factors which determine whether or not a patient will have kidney stones. 
Patients may have marked hypercalciuria for long periods without developing kidney 
stones. On the other hand, there are many patients with normal urinary calcium 
excretion who have repeated calcium nephrolithiasis. 
In general, the determination of the urinary calcium excretion is not of much 
help in the diagnosis of hyperparathyroidism since almost all conditions causing hyper-
calcemia also have associated hypercalciuria. An exception is the milk alkali syndrome 
where, because of renal insufficiency, urinary calcium excretion is normal or decreased 
despite hypercalcemia. Reduced calciuria also occurs in other hypercalcemic con-
ditions after the development of significant renal failure. The hypercalciuria of 
hyperthyroidism may be extreme, but seldom do such patients have nephrolithiasis. 
The cause for this is not known. The calciuria in involutional osteoporosis is 
variable, probably because there are many causes of osteoporosis and only certain 
types are accompanied by increased urinary calcium excretion. The incidence of 
kidney stones in patients with Cushing's disease has been a significant complication 
in some series. In multiple myeloma and metastatic cancer the renal excretion of 
calcium may be greatly increased, but rarely do these patients present with 
kidney stones. Hypercalciuria in renal tubular acidosis is variable and does not seem 
to be the determinant factor in the occurrence of kidney stones. The reduction 
of urinary citrate that occurs in the syndrome may be an important considera-
tion in this regard. The hypercalciuria in the Fanconi syndrome again may 
be quite marked, but only occasionally are kidney stones a problem. Perhaps the 
associated aminoaciduria present in the syndrome helps maintain calcium in solution 
by enhancing chelation with amino acids. 
There are several subclassifications of the entity known as idiopathic hyper-
calciuria which is frequently accompanied by recurrent nephrolithiasis and which may 
be difficult to distinguish from hyperparathyroidism. In some instances, the hyper-
calciuria is accompanied by hypophosphatemia, but the serum calcium is normal. 
Two separate theories have been postulated to explain idiopathic hypercalciuria. One 
theory is a primary renal tubular defect for calcium resulting in hypercalciuria and 
a tendency towards early hypocalcemia, which is then corrected by a secondary 
hyperparathyroidism. The latter would account for the depression of serum phosphorus 
often present in the condition. The other incriminates a hyperabsorption of calcium 
from the intestinal tract and thence secondary hypercalciuria. Theoretically, one 
would expect in the latter instance a depression of the parathyroid glands and an 
increased serum inorganic phosphorus, but this does not occur. Nevertheless, evidence 
obtained in balance studies after the administration of sodium phytate and cellulose 
phosphate supports the contention that hyperabsorption of calcium may be an important 
factor. Under these circumstances, fecal calcium is increased and urine calcium 
decreased without the occurrence of a negative calcium balance.'" It has also been 
demonstrated that certain of the newer diuretic agents such as bendrofluorazide 
decreases urinary calcium excretion in patients with idiopathis hypercalciuria.'"" The 
concurrent administration of both cellulose phosphate and bendrofluorazide is probabl)' 
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the best present method of reducing urinary calcium excretion in patients with idio-
pathis hypercalcuria and recurrent nephrolithiasis. 
URIC A C I D STONES 
The radiolucent renal stone is almost always composed of uric acid except for 
the rare cases of glycinuria and xanthinuria. Metabolic evaluation in patients with 
uric acid lithiasis brings into consideration many etiologic factors. The patient may 
have classic gout or only a family history of gout. In the latter mstance, hyperuricemia 
and also an increased urinary excretion of uric acid is usually present. The deter-
mination of both the serum and urinary uric acid may be misleading, especially if 
the patient has been on salicylates or diuretic agents. Some patients with uric acid 
lithiasis have hyperuricemia and hyperuricosuria without a past, personal or family 
history of gout. Other family members may also have increased concentration of 
uric acid in the serum and urine without evidence of gout. These patients are said 
to have essential or idiopathic hyperuricemia. Uric acid Hthiasis may be a serious 
problem in these patients and to protect the kidney against gouty nephropathy, they 
should be treated with uricosuric agents as vigorously as if they had true gout. 
There is also an increased incidence of uric acid stones in patients with chronic 
enteritis and colitis.'" In this instance the diversion of water excretion to the bowel 
results in a decreased urinary flow and a persistentiy acid pH of the urine which 
predispose to uric acid lithiasis. 
Not infrequently patients with uric acid lithiasis will have normal concentrations 
of uric acid in the serum and urine. In this instance, a persistently acid pH of the 
urine is frequently observed. It has ben postulated that these patients have a renal 
tubular defect for effective urinary alkalinization which predisposes to uric acid 
crystaUzation. It has been suggested that a defect in ammonia production by the 
kidney in such patients may be an important limiting factor. 
Patients with uric acid lithiasis should always be evaluated for underiying blood 
dyscrasias such as leukemia, lymphoma and myeloproliferative disorders. Uric acid 
stones are especially likely to occur following treatment of leukemia with various 
antileukemic agents where there is an increased breakdown of nucleoprotein. 
The traditional therapy of uric acid lithiasis has been fluid administration and 
alkalinization of the urine. Administration of uricosuric agents such as benemid 
may temporarily aggravate uric acid stone formation by an initial increase in uric 
acid excretion. A recent new approach offers promising therapy for the future. 
Allopurinol, a xanthine oxidase inhibitor, has been found to reduce synthesis of 
uric acid and thereby reduce its urinary excretion. This therapy may be especially 
helpful in those patients with gouty nephritis and ureteral obstruction from uric acid 
crystallization. Allopurinol may be used in conjunction with other modes of therapy 
including urinary alkalinization and uricosuric agents. One theoretic objection, that 
has not been a problem to date, is that the increased urinary excretion of xanthine 
occurring after the administration of Allopurinol may conceivably lead to increased 




A rare and interesting metabolic defect leading to nephrolithiasis is that of 
cystinuria. A family history of nephrolithiasis and onset early in life should lead 
one to suspect this diagnosis. The typical hexagonal crystals of cystine are readily 
identifiable in the urinary sediment. Urinary chromatography may also be of help 
in identifying the increased urinary excretion of not only cystine but also' other 
dibasic amino acids such as lysine, glysine and ornithine. Recent evidence has thrown 
some doubts upon the long accepted theory of a renal transport defect for cystine 
in this condition. The renal tubular transport defect may actually involve cysteine 
rather than cystine.'^ 
The time honored therapy for cystinuria has been similar to that for uric acid 
lithiasis, mainly hydration and urinary alkalinization. Night time hydration has been 
stressed as an important factor in prevention of cystine crystalization. Recentiy a 
new approach to the treatment of cystinuria has been introduced." It has been 
demonstrated that D-penicillamine can combine as a disulphide linkage with cysteine and 
thence be excreated in the urine. Since D-penicillamine cysteine is more soluble than 
cystine itself, cystine lithiasis is less likely to occur. At the present time, D-penicillamine 
is an expensive mode of therapy, but perhaps production costs can be reduced. Also 
other similar, but less expensive agents undoubtedly will be introduced. In some 
instances, skin rash and signs of renal irritation have necessitated the discontinuance 
of D-penicillamine." 
UNUSUAL STONES 
Silicate stones are common in cattle where there is an increased intake of sand 
and dirt present in hay and other feed. The use of certain antacids such as magnesium 
trisilicate have also been rarely reported to be associated with the formation of 
silicate stones in man. The finding of silicate stones in the urine should also raise 
the possibility of malingering. Such was the experience at this hospital several years 
ago when a female patient brought in several small pebble-like stones that she 
claimed she had passed in the urine. These stones proved to be calcium silicate by 
x-ray diffraction and , when faced with the evidence, the patient admitted that she 
had selected the stones from her driveway. She used the story of nephrolithiasis and 
renal colic as a method of obtaining narcotics. 
Rare instances of xanthine stones have been reported in the literature. As 
mentioned previously, the use of Allopurinol in the treatment of uric acid lithiasis 
may theoretically increase the tendency towards xanthine stone formation. 
Rarely, renal tubular defects for other amino acids such as glycine have led 
to formation of pure amino acid stones. These unusual conditions are best diagnosed 
by the use of urinary paper or column chromatography. Rarely in the metabolic 
defect alkaptinuria precipitation of the dark stones containing homogentisic acid 
occurs in the urine. 
In this discussion of nephrolithiasis the important factors of urinary obstruction 
and infection have been omitted. These certainly complicate diagnosis and thera.py 
but are major subjects in themselves. 
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SUMMARY 
The corerct medical diagnosis of kidney stones requires the concerted and 
cooperative effort of the internist, urologist and clinical pathologist. Stone analysis 
early will often give a clue to the metabolic error and prevent many unnecessary 
and expensive laboratory procedures. Once the stone is defined as being calcium, 
uric acid or cystine stone, the metabolic studies can be planned in a logical 
sequence. Early definition of the metabolic defect before the occurrence of infection 
or renal insufficiency not only simplifies investigation, but also allows for early 
definitive therapy in most instances. It is the physician's duty to encourage the 
patient with kidney stones to submit to an early and adequate metabolic evaluation. 
In the long run this will undoubtedly save the patient time, convenience and expense, 
in addition to decreasing the chance of renal insufficiency. Treatment of pain, 
infection and obstruction in a patient with urinary tract stones without adequate 
metabolic evaluation is to be condemned. 
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